Literature DB >> 23756244

The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function.

Geraldine M O'Connor1, Daniel McVicar.   

Abstract

Killer Immunoglobulin-like Receptors (KIR) are a family of receptors expressed on natural killer (NK) and T-cell subsets. KIR3DL1 is a highly polymorphic receptor that binds to groups of HLAA and HLA-B allotypes that express the Bw4 epitope. The variation in KIR3DL1 allotypes manifests at a number of levels. Most dramatically, a common allelic variant encodes an activating rather than an inhibitory receptor (KIR3DS1). In addition, sequence variants can affect both the frequency of expression within the NK cell population and the intensity of expression on a given cell. KIR3DL1 polymorphism also influences the interaction with HLA-Bw4 molecules, due to contacts with the HLA molecule itself and sensitivity to the presented peptide. A body of evidence from genetic association studies supports the biological significance not only of the interaction of KIR3DL1 with HLA-Bw4 but also the functional variation seen with different KIR3DL1 and HLA allotypes. In this review, we discuss our current understanding of KIR3DL1 function and our recent insights from the structure of the KIR3DL1 in complex with HLA. In addition, we will summarize our current understanding of KIR3DS1, including its ligand specificity and its role in immune responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756244      PMCID: PMC3741655          DOI: 10.1615/critrevimmunol.2013007409

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  75 in total

Review 1.  Early signaling via inhibitory and activating NK receptors.

Authors:  M Bléry; L Olcese; E Vivier
Journal:  Hum Immunol       Date:  2000-01       Impact factor: 2.850

2.  Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1.

Authors:  Iris A Halfpenny; Derek Middleton; Yvonne A Barnett; Fionnuala Williams
Journal:  Hum Immunol       Date:  2004-06       Impact factor: 2.850

3.  Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.

Authors:  C M Gardiner; L A Guethlein; H G Shilling; M Pando; W H Carr; R Rajalingam; C Vilches; P Parham
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

4.  Peptide specificity in the recognition of MHC class I by natural killer cell clones.

Authors:  M S Malnati; M Peruzzi; K C Parker; W E Biddison; E Ciccone; A Moretta; E O Long
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

5.  Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells.

Authors:  Yong-Joon Chwae; Mi Jung Chang; Sang Myun Park; Ho Yoon; Hyun-Joo Park; Se Jong Kim; Jongsun Kim
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

6.  The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1.

Authors:  Marcelo J Pando; Clair M Gardiner; Michael Gleimer; Karina L McQueen; Peter Parham
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

7.  KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.

Authors:  Akiko Kikuchi-Maki; Sei-ichi Yusa; Tracey L Catina; Kerry S Campbell
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

8.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Authors:  Maureen P Martin; Xiaojiang Gao; Jeong-Hee Lee; George W Nelson; Roger Detels; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; John Trowsdale; Michael Wilson; Stephen J O'Brien; Mary Carrington
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

9.  The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer.

Authors:  Salim I Khakoo; Ron Geller; Sunny Shin; Jomaquai A Jenkins; Peter Parham
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

10.  NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.

Authors:  M Cella; A Longo; G B Ferrara; J L Strominger; M Colonna
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  9 in total

1.  Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Authors:  Charles L Dulberger; Curtis P McMurtrey; Angelique Hölzemer; Karlynn E Neu; Victor Liu; Adriana M Steinbach; Wilfredo F Garcia-Beltran; Michael Sulak; Bana Jabri; Vincent J Lynch; Marcus Altfeld; William H Hildebrand; Erin J Adams
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 2.  Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.

Authors:  Jeanette E Boudreau; Katharine C Hsu
Journal:  Trends Immunol       Date:  2018-01-31       Impact factor: 16.687

Review 3.  Natural killer cell education in human health and disease.

Authors:  Jeanette E Boudreau; Katharine C Hsu
Journal:  Curr Opin Immunol       Date:  2018-02-03       Impact factor: 7.486

4.  Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells.

Authors:  E Townsley; G O'Connor; C Cosgrove; M Woda; M Co; S J Thomas; S Kalayanarooj; I-K Yoon; A Nisalak; A Srikiatkhachorn; S Green; H A F Stephens; E Gostick; D A Price; M Carrington; G Alter; D W McVicar; A L Rothman; A Mathew
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

5.  Cervical Cancer Cells Express Markers Associated with Immunosurveillance.

Authors:  Adriana Gutiérrez-Hoya; Octavio Zerecero-Carreón; Arturo Valle-Mendiola; Martha Moreno-Lafont; Rubén López-Santiago; Benny Weiss-Steider; Isabel Soto-Cruz
Journal:  J Immunol Res       Date:  2019-05-06       Impact factor: 4.818

6.  Donor KIR3DL1/receptor HLA-Bw4-80I Combination Reduces Acute Leukemia Relapse after Umbilical Cord Blood Transplantation without in Vitro T-cell Depletion.

Authors:  Xinchen Fang; Xiaoyu Zhu; Baolin Tang; Kaidi Song; Wen Yao; Xiang Wan; Huilan Liu; Jun Peng; Zimin Sun
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-01-01       Impact factor: 2.576

7.  Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.

Authors:  Genelle F Harrison; Laura Ann Leaton; Erica A Harrison; Katherine M Kichula; Marte K Viken; Jonathan Shortt; Christopher R Gignoux; Benedicte A Lie; Damjan Vukcevic; Stephen Leslie; Paul J Norman
Journal:  PLoS Comput Biol       Date:  2022-02-22       Impact factor: 4.475

8.  Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles.

Authors:  Jeanette E Boudreau; Jean-Benoît Le Luduec; Katharine C Hsu
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

9.  A Coevolutionary Arms Race between Hosts and Viruses Drives Polymorphism and Polygenicity of NK Cell Receptors.

Authors:  Paola Carrillo-Bustamante; Can Keşmir; Rob J de Boer
Journal:  Mol Biol Evol       Date:  2015-04-23       Impact factor: 16.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.